Dr Richard Hansen

Honorary Clinical Associate Professor (School of Medicine, Dentistry & Nursing)

Publications

List by: Type | Date

Jump to: 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Number of items: 51.

2024

White, B., Curle, J., Gervais, L., Wands, D., Nichols, B., Hansen, R., Russell, R. K., Gerasimidis, K. and Milling, S. (2024) Exclusive enteral nutrition impacts peripheral blood mononuclear cell profile of children with Crohn’s disease. Journal of Pediatric Gastroenterology and Nutrition, (Accepted for Publication)

Nichols, B. et al. (2024) Gut metabolome and microbiota signatures predict response to treatment with exclusive enteral nutrition in a prospective study in children with active Crohn’s disease. American Journal of Clinical Nutrition, 119(4), pp. 885-895. (doi: 10.1016/j.ajcnut.2023.12.027) (PMID:38569785) (PMCID:PMC11007740)

Gkikas, K. , Svolos, V., Hansen, R., Russell, R. K. and Gerasimidis, K. (2024) Take-home messages from 20 years progress in dietary therapy of inflammatory bowel disease. Annals of Nutrition and Metabolism, 79(6), pp. 476-484. (doi: 10.1159/000535007) (PMID:37944498)

2023

Jatkowska, A. et al. (2023) Development and validation of the Glasgow Exclusive Enteral Nutrition Index of Compliance. Journal of Crohn's and Colitis, 17(9), pp. 1426-1435. (doi: 10.1093/ecco-jcc/jjad063) (PMID:37004165) (PMCID:PMC10588781)

Wands, D. I. F., Gianolio, L., Wilson, D. C., Hansen, R., Chalmers, I., Henderson, P., Gerasimidis, K. and Russell, R. K. (2023) Nationwide real-world exclusive enteral nutrition practice over time: persistence of use as induction for paediatric Crohn’s Disease and emerging combination strategy with biologics. Inflammatory Bowel Diseases, (doi: 10.1093/ibd/izad167) (PMID:37619221) (Early Online Publication)

Gkikas, K. , Wan, M., Svolos, V., Nichols, B., Hansen, R., Russell, R. K. and Gerasimidis, K. (2023) YouTube as a source of information for food, diet-related items, and advisory comments for the management of inflammatory bowel disease. Inflammatory Bowel Diseases, (doi: 10.1093/ibd/izad076) (Early Online Publication)

2022

Kelly, P. E., Ng, H. J., Farrell, G., McKirdy, S., Russell, R. K., Hansen, R., Rattray, Z., Gerasimidis, K. and Rattray, N. J. W. (2022) An optimised monophasic faecal extraction method for LC-MS analysis and its application in gastrointestinal disease. Metabolites, 12(11), 1110. (doi: 10.3390/metabo12111110) (PMID:36422250) (PMCID:PMC9698041)

Torrente, F. et al. (2022) Thromboprophylaxis use in paediatric inflammatory bowel disease: an international RAND appropriateness panel. Journal of Crohn's and Colitis, 16(10), pp. 1609-1616. (doi: 10.1093/ecco-jcc/jjac073) (PMID:35608932) (PMCID:PMC9624289)

Mckirdy, S., Russell, R. K., Svolos, V., Gkikas, K. , Logan, M. , Hansen, R. and Gerasimidis, K. (2022) The impact of compliance during exclusive enteral nutrition on faecal calprotectin in children with Crohn’s disease. Journal of Pediatric Gastroenterology and Nutrition, 74(6), pp. 801-804. (doi: 10.1097/MPG.0000000000003425) (PMID:35192573)

Logan, M. , Mackinder, M., Clark, C. M., Kountouri, A., Jere, M., Ijaz, U. Z. , Hansen, R., McGrogan, P., Russell, R. K. and Gerasimidis, K. (2022) Intestinal fatty acid binding protein is a disease biomarker in paediatric coeliac disease and Crohn’s disease. BMC Gastroenterology, 22, 260. (doi: 10.1186/s12876-022-02334-6) (PMID:35606704) (PMCID:PMC9125891)

Gerasimidis, K. et al. (2022) The effects of commonly consumed dietary fibres on the gut microbiome and its fibre fermentative capacity in adults with inflammatory bowel disease in remission. Nutrients, 14(5), 1053. (doi: 10.3390/nu14051053) (PMID:35268028) (PMCID:PMC8912623)

2021

Gkikas, K. et al. (2021) Dietary triggers of gut inflammation following exclusive enteral nutrition in children with Crohn’s disease: a pilot study. BMC Gastroenterology, 21, 454. (doi: 10.1186/s12876-021-02029-4) (PMID:34861829)

McGrogan, L. et al. (2021) Micronutrient deficiencies in children with coeliac disease; a double-edged sword of both untreated disease and treatment with gluten-free diet. Clinical Nutrition, 40(5), pp. 2784-2790. (doi: 10.1016/j.clnu.2021.03.006) (PMID:33933744)

Jere, M., Garrick, V., Curtis, L., Tayler, R., Gervais, L., Gerasimidis, K. and Hansen, R. (2021) Point-of-care faecal calprotectin testing in patients with paediatric inflammatory bowel disease during the COVID-19 pandemic. BMJ Open Gastroenterology, 8(1), e000631. (doi: 10.1136/bmjgast-2021-000631) (PMID:33947712) (PMCID:PMC8098232)

2020

Zafeiropoulou, K. et al. (2020) Alterations in intestinal microbiota of children with celiac disease at time of diagnosis and on a gluten-free diet. Gastroenterology, 159(6), 2039-2051.e20. (doi: 10.1053/j.gastro.2020.08.007) (PMID:32791131) (PMCID:PMC7773982)

Maclean, A., Ashton, J. J., Garrick, V., Beattie, R.M. and Hansen, R. (2020) Impact of COVID-19 on the diagnosis, assessment and management of children with inflammatory bowel disease in the UK: implications for practice. BMJ Paediatrics Open, 4(1), e000786. (doi: 10.1136/bmjpo-2020-000786) (PMCID:PMC7549416)

Gerasimidis, K. , Bryden, K., Chen, X., Papachristou, E., Verney, A., Roig, M., Hansen, R., Nichols, B., Papadopoulou, R. and Parrett, A. (2020) The impact of food additives, artificial sweeteners and domestic hygiene products on the human gut microbiome and its fibre fermentation capacity. European Journal of Nutrition, 59(7), pp. 3213-3230. (doi: 10.1007/s00394-019-02161-8) (PMID:31853641) (PMCID:PMC7501109)

Gkikas, K. , Gerasimidis, K. , Milling, S. , Ijaz, U. Z. , Hansen, R. and Russell, R. (2020) Dietary strategies for maintenance of clinical remission in inflammatory bowel diseases: Are we there yet? Nutrients, 12(7), 2018. (doi: 10.3390/nu12072018) (PMID:32645980) (PMCID:PMC7400838)

Kennedy, N. A. et al. (2020) British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic. Gut, 69(6), pp. 984-990. (doi: 10.1136/gutjnl-2020-321244) (PMID:32303607) (PMCID:PMC7211081)

Logan, M. et al. (2020) Analysis of 61 exclusive enteral nutrition formulas used in management of active Crohn's disease - new insights into dietary disease triggers. Alimentary Pharmacology and Therapeutics, 51(10), pp. 935-947. (doi: 10.1111/apt.15695) (PMID:32249975)

Ormsby, M. et al. (2020) Propionic acid promotes the virulent phenotype of Crohn's disease-associated adherent-invasive Escherichia coli. Cell Reports, 30(7), 2297-2305.e5. (doi: 10.1016/j.celrep.2020.01.078) (PMID:32075765) (PMCID:PMC7034058)

2019

Lamb, C. A. et al. (2019) British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut, 68(Suppl3), s1-s106. (doi: 10.1136/gutjnl-2019-318484) (PMID:31562236) (PMCID:PMC6872448)

Quraishi, M. N. N. et al. (2019) STOP-Colitis pilot trial protocol: a prospective, open-label, randomised pilot study to assess two possible routes of faecal microbiota transplant delivery in patients with ulcerative colitis. BMJ Open, 9(11), e030659. (doi: 10.1136/bmjopen-2019-030659) (PMID:31719078) (PMCID:PMC6858155)

Gerasimidis, K. , Svolos, V., Nichols, B., Papadopoulou, R., Quince, C., Ijaz, U. Z. , Milling, S. , Gaya, D. R., Russell, R. K. and Hansen, R. (2019) Reply. Gastroenterology, 157(4), pp. 1161-1162. (doi: 10.1053/j.gastro.2019.08.015) (PMID:31408620)

Logan, M. et al. (2019) The reduction of faecal calprotectin during exclusive enteral nutrition is lost rapidly after food re-introduction. Alimentary Pharmacology and Therapeutics, 50(6), pp. 664-674. (doi: 10.1111/apt.15425) (PMID:31342536) (PMCID:PMC6772069)

Hansen, R., Gerasimidis, K. and Turner, S. (2019) Asthma causation and the gastrointestinal microbiome and metabolome: might there be a signal, or is it just noise? Journal of Allergy and Clinical Immunology, 144(2), pp. 401-403. (doi: 10.1016/j.jaci.2019.04.026) (PMID:31078572)

Ormsby, M. J. et al. (2019) Inflammation associated ethanolamine facilitates infection by Crohn's disease-linked adherent-invasive Escherichia coli. EBioMedicine, 43, pp. 325-332. (doi: 10.1016/j.ebiom.2019.03.071) (PMID:31036531) (PMCID:PMC6557746)

Svolos, V. et al. (2019) Treatment of active Crohn’s disease with an ordinary food-based diet that replicates exclusive enteral nutrition. Gastroenterology, 156(5), 1354-1367.e6. (doi: 10.1053/j.gastro.2018.12.002) (PMID:30550821)

2018

McIlroy, J., Ianiro, G., Mukhopadhya, I., Hansen, R. and Hold, G.L. (2018) Review article: the gut microbiome in inflammatory bowel disease-avenues for microbial management. Alimentary Pharmacology and Therapeutics, 47(1), pp. 26-42. (doi: 10.1111/apt.14384) (PMID:29034981)

Richmond, L., Curtis, L., Garrick, V., Rogers, P., Wilson, M., Tayler, R., Henderson, P., Hansen, R., Wilson, D. C. and Russell, R. K. (2018) Biosimilar infliximab use in paediatric IBD. Archives of Disease in Childhood, 103(1), pp. 89-91. (doi: 10.1136/archdischild-2017-313404) (PMID:28988215)

2017

Logan, M. , Ijaz, U.Z. , Hansen, R., Gerasimidis, K. and Russell, R.K. (2017) Letter: reproducible evidence shows that exclusive enteral nutrition significantly reduces faecal calprotectin concentrations in children with active Crohn's Disease. Alimentary Pharmacology and Therapeutics, 46(11-12), pp. 1119-1120. (doi: 10.1111/apt.14351) (PMID:29105140)

Ijaz, U. Z. et al. (2017) The distinct features of microbial 'dysbiosis' of Crohn's disease do not occur to the same extent in their unaffected, genetically linked kindred. PLoS ONE, 12(2), e0172605. (doi: 10.1371/journal.pone.0172605) (PMID:28222161) (PMCID:PMC5319678)

Svolos, V. et al. (2017) Dietary Manipulation of the Healthy Human and Colitic Murine Gut Microbiome by CD-TREAT Diet and Exclusive Enteral Nutrition; A Proof of Concept Studyy. 12th Congress of ECCO, Barcelona, Spain, 15-18 Feb 2017. S29-S30. (doi: 10.1093/ecco-jcc/jjx002.045)

Svolos, V. et al. (2017) Dietary treatment of Crohn’s disease: perceptions of families with children treated by exclusive enteral nutrition, a questionnaire survey. BMC Gastroenterology, 17, 14. (doi: 10.1186/s12876-016-0564-7) (PMID:28103809) (PMCID:PMC5247812)

2016

Gerasimidis, K. , Ijaz, U. Z. , Edwards, C. , Russell, R. K., Quince, C. and Hansen, R. (2016) Response to Kaakoush et al. American Journal of Gastroenterology, 111(7), pp. 1033-1034. (doi: 10.1038/ajg.2016.169) (PMID:27356826)

Svolos, V., Hansen, R., Hughes, K., Ijaz, U.Z. , Quince, C., Gaya, D., Russell, R. and Gerasimidis, K. (2016) The Impact of ‘Crohn’s Disease-TReatment-with-EATing’ Diet (CD-TREAT Diet) and Exclusive Enteral Nutrition on Healthy Gut Bacteria Metabolism. 11th Congress of the European Crohn's and Colitis Organisation, Amsterdam, The Netherlands, 16-19 March 2016. S14-S15. (doi: 10.1093/ecco-jcc/jjw019.017)

2015

Quince, C. et al. (2015) Extensive modulation of the fecal metagenome in children with Crohn’s Disease during exclusive enteral nutrition. American Journal of Gastroenterology, 110, pp. 1718-1729. (doi: 10.1038/ajg.2015.357) (PMID:26526081)

Hansen, R., Russell, R. K. and Muhammed, R. (2015) Recent advances in paediatric gastroenterology. Archives of Disease in Childhood, 100(9), pp. 886-890. (doi: 10.1136/archdischild-2014-307089) (PMID:25710546)

Mukhopadhya, I., Hansen, R., Meharg, C., Thomson, J.M., Russell, R.K., Berry, S.H., El-Omar, E.M. and Hold, G.L. (2015) The fungal microbiota of de-novo paediatric inflammatory bowel disease. Microbes and Infection, 17(4), pp. 304-310. (doi: 10.1016/j.micinf.2014.12.001) (PMID:25522934) (PMCID:PMC4392392)

Hansen, R., Scott, K. P., Khan, S., Martin, J. C., Berry, S. H., Stevenson, M., Okpapi, A., Munro, M. J. and Hold, G. L. (2015) First-pass meconium samples from healthy term vaginally-delivered neonates: an analysis of the microbiota. PLoS ONE, 10(7), e0133320. (doi: 10.1371/journal.pone.0133320) (PMID:26218283) (PMCID:PMC4517813)

2014

Adams, A. T. et al. (2014) Two-stage genome-wide methylation profiling in childhood-onset Crohnʼs disease implicates epigenetic alterations at the VMP1/MIR21 and HLA loci. Inflammatory Bowel Diseases, 20(10), pp. 1784-1793. (doi: 10.1097/MIB.0000000000000179) (PMID:25144570)

Gerasimidis, K. , Russell, R., Hansen, R., Quince, C., Loman, N., Bertz, M., Hanske, L., Blaut, M., McGrogan, P. and Edwards, C. A. (2014) Role of Faecalibacterium prausnitzii in Crohnʼs Disease. Inflammatory Bowel Diseases, 20(7), E18-E19. (doi: 10.1097/MIB.0000000000000079)

2013

Hansen, R. et al. (2013) The microaerophilic microbiota of de-novo paediatric inflammatory bowel disease: the BISCUIT study. PLoS ONE, 8(3), e58825. (doi: 10.1371/journal.pone.0058825) (PMID:23554935) (PMCID:PMC3595230)

2012

Hansen, R. et al. (2012) Microbiota of de-novo pediatric IBD: increased faecalibacterium prausnitzii and reduced bacterial diversity in crohn's but not in ulcerative colitis. American Journal of Gastroenterology, 107(12), pp. 1913-1922. (doi: 10.1038/ajg.2012.335)

Henderson, P. et al. (2012) Rising incidence of pediatric inflammatory bowel disease in Scotland. Inflammatory Bowel Diseases, 18(6), pp. 999-1005. (doi: 10.1002/ibd.21797) (PMID:21688352)

Mukhopadhya, I., Hansen, R., El-Omar, E. M. and Hold, G. L. (2012) IBD—what role do proteobacteria play? Nature Reviews Gastroenterology and Hepatology, 9(4), pp. 219-230. (doi: 10.1038/nrgastro.2012.14) (PMID:22349170)

2011

Hansen, R., Thomson, J. M., Fox, J. G., El-Omar, E. M. and Hold, G. L. (2011) Could Helicobacter organisms cause inflammatory bowel disease? FEMS Immunology and Medical Microbiology, 61(1), pp. 1-14. (doi: 10.1111/j.1574-695X.2010.00744.x) (PMID:20955468)

Mukhopadhya, I. et al. (2011) A comprehensive evaluation of colonic mucosal isolates of sutterella wadsworthensis from inflammatory bowel disease. PLoS ONE, 6(10), e27076. (doi: 10.1371/journal.pone.0027076)

Mukhopadhya, I., Thomson, J. M., Hansen, R., Berry, S. H., El-Omar, E. M. and Hold, G. L. (2011) Detection of campylobacter concisus and other campylobacter species in colonic biopsies from adults with ulcerative colitis. PLoS ONE, 6(6), e21490. (doi: 10.1371/journal.pone.0021490) (PMID:21738679) (PMCID:PMC3124515)

Thomson, J. M. et al. (2011) Enterohepatic helicobacter in ulcerative colitis: potential pathogenic entities? PLoS ONE, 6(2), e17184. (doi: 10.1371/journal.pone.0017184) (PMID:21383845) (PMCID:PMC3044171)

2010

Hansen, R., Cameron, F. L., Hold, G. L., El-Omar, E. M. and Russell, R. K. (2010) Inflammatory bowel disease. Paediatrics and Child Health, 20(10), pp. 473-478. (doi: 10.1016/j.paed.2010.04.005)

This list was generated on Thu Apr 25 19:12:52 2024 BST.

Jump to: Articles | Conference or Workshop Item